Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients

Clinical trial NCT06073730 · UNKNOWN

Trial details

NCT number: NCT06073730
Sponsor: The Second Affiliated Hospital of Kunming Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Elderly AML Patients Unfit, New-diagnosis AML Acute Myeloid Leukemia Venetoclax Decitabine

Start date: 2023-11-01
Primary completion: 2024-11-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.